Casdin Capital, LLC

Average Profitability
24.74%
Insider Buys Quantity
15
Insider Buys Sum
$41.79M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Casdin Capital, LLC

According to the SEC Form 4 filings, Casdin Capital, LLC, being in a position of

  1. director at 2seventy bio, Inc.,
    оver the last 12 months, has bought 817377 shares for $4.1M, and sold 0 shares,
    over all time since 2024-03-21, has bought 817377 shares for $4.1M, and sold 0 shares.

The largest purchase of all time was on 2020-06-16 and amounted to 1300000 shares of Generation Bio Co. for $24.7M.

Biography of Casdin Capital, LLC

No biography is available at this moment.

2024-06-04PurchaseGeneDx Holdings Corp.
WGS
30,000
0.0314%
$22.52$675,477+52.86%
2024-06-03PurchaseGeneDx Holdings Corp.
WGS
100,000
0.0967%
$20.82$2.08M+69.23%
2024-05-29PurchaseGeneDx Holdings Corp.
WGS
40,000
0.0391%
$21.07$842,604+68.27%
2024-05-28PurchaseGeneDx Holdings Corp.
WGS
18,304
0.0175%
$20.61$377,167+73.21%
2024-05-24PurchaseGeneDx Holdings Corp.
WGS
144,196
0.1347%
$20.12$2.9M+72.48%
2024-05-23PurchaseGeneDx Holdings Corp.
WGS
7,500
0.0068%
$19.59$146,916+79.72%
2024-05-13PurchaseGeneDx Holdings Corp.
WGS
50,000
0.0541%
$23.31$1.17M+47.56%
2024-03-26Purchase2seventy bio, Inc.
TSVT
director
40,000
0.0812%
$5.10$203,992-8.27%
2024-03-25Purchase2seventy bio, Inc.
TSVT
director
330,000
0.6747%
$5.07$1.67M-7.14%
2024-03-22Purchase2seventy bio, Inc.
TSVT
director
147,377
0.2903%
$5.12$754,069-11.21%
2024-03-21Purchase2seventy bio, Inc.
TSVT
director
300,000
0.5822%
$4.90$1.47M-8.98%
2024-03-05PurchaseGeneDx Holdings Corp.
WGS
900
0.0004%
$8.83$7,944+272.28%
2024-03-04PurchaseGeneDx Holdings Corp.
WGS
40,000
0.0162%
$8.74$349,708+262.5%
2020-06-16PurchaseGeneration Bio Co.
GBIO
10 percent owner
1.3M
10.4125%
$19.00$24.7M+47.36%
2019-07-22PurchaseFulcrum Therapeutics, Inc.
FULC
10 percent owner
280,000
1.9482%
$15.84$4.43M+2.11%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.